KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions: 2017-2023

Historic Acquisitions for Exact Sciences (EXAS) over the last 3 years, with Dec 2023 value amounting to $2.4 million.

  • Exact Sciences' Acquisitions fell 84.30% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $66.4 million, marking a year-over-year decrease of 32.82%. This contributed to the annual value of $52.4 million for FY2023, which is 256.89% up from last year.
  • Exact Sciences' Acquisitions amounted to $2.4 million in Q4 2023, which was down 95.17% from $50.0 million recorded in Q3 2023.
  • In the past 5 years, Exact Sciences' Acquisitions ranged from a high of $973.9 million in Q4 2019 and a low of -$1.4 million during Q3 2022.
  • Its 3-year average for Acquisitions is $70.9 million, with a median of $32.7 million in 2022.
  • Per our database at Business Quant, Exact Sciences' Acquisitions skyrocketed by 47,355.56% in 2021 and then tumbled by 99.05% in 2022.
  • Quarterly analysis of 5 years shows Exact Sciences' Acquisitions stood at $973.9 million in 2019, then reached $4,000 in 2020, then spiked by 47,355.56% to $84.2 million in 2021, then plummeted by 81.74% to $15.4 million in 2022, then tumbled by 84.30% to $2.4 million in 2023.
  • Its Acquisitions stands at $2.4 million for Q4 2023, versus $50.0 million for Q3 2023 and $15.4 million for Q4 2022.